Differences in prescription patterns between real-world outpatients with bipolar I and II disorders in the MUSUBI survey

Author:

Shinozaki Masataka,Yasui-Furukori Norio,Adachi Naoto,Ueda Hitoshi,Hongo Seiji,Azekawa Takaharu,Kubota Yukihisa,Katsumoto Eiichi,Edagawa Koji,Goto Eiichiro,Miki Kazuhira,Kato Masaki,Nakagawa Atsuo,Kikuchi Toshiaki,Tsuboi Takashi,Watanabe Koichiro,Shimoda Kazutaka,Yoshimura Reiji

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,General Psychology,General Medicine

Reference29 articles.

1. Estimated model of psychotropic polypharmacy for bipolar disorder: Analysis using patients’ and practitioners’ parameters in the MUSUBI study;Adachi;Hum. Psychopharmacol.,2020

2. Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study;Amsterdam;Am. J. Psychiatry,2010

3. Short-term venlafaxine v. lithium monotherapy for bipolar type II major depressive episodes: effectiveness and mood conversion rate;Amsterdam;Br. J. Psychiatry.: J. Ment. Sci.,2016

4. Diagnostic and Statistical Manual of Mental Disorders;Association, American Psychiatric,2013

5. Differences between bipolar I and bipolar II disorders in clinical features, comorbidity, and family history;Baek;J. Affect. Disord.,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3